Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

JACC: Cardiovascular Interventions

Volumn 7, Issue 6, 2014, Pages 592-601

  Yang, Jeong Hoon ^a   Hahn, Joo Yong ^a   Song, Young Bin ^a   Choi, Seung Hyuk ^a   Choi, Jin Ho ^a   Lee, Sang Hoon ^a   Kim, Joo Han ^b   Ahn, Young Keun ^b   Jeong, Myung Ho ^b   Choi, Dong Joo ^c   Park, Jong Seon ^d   Kim, Young Jo ^d   Park, Hun Sik ^e   Han, Kyoo Rok ^f   Rha, Seung Woon ^g   Gwon, Hyeon Cheol ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Young Nam University Hospital   (South Korea)

^e Kyungpook National University Hospital   (South Korea)

^f Kangdong Sacred Heart Hospital   (South Korea)

^g Korea University Ansan Hospital   (South Korea)

Author keywords

angioplasty; beta blocker; myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CAUSE OF DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; LOADING DRUG DOSE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROCEDURES; PROPENSITY SCORE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; SECONDARY PREVENTION; SOUTH KOREA; SURVIVAL RATE; TIME; TREATMENT OUTCOME; TRENDS;

ADRENERGIC BETA-ANTAGONISTS; AGED; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PERCUTANEOUS CORONARY INTERVENTION; PROPENSITY SCORE; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; REPUBLIC OF KOREA; RISK FACTORS; SECONDARY PREVENTION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84902797164     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.12.206     Document Type: Article

References (22)

1. P.T. O'Gara, F.G. Kushner, and D.D. Ascheim et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 E78 E140
2. S. Yusuf, R. Peto, J. Lewis, R. Collins, and P. Sleight Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 1985 335 371
3. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction N Engl J Med 304 1981 801 807
4. S.J. Kernis, K.J. Harjai, and G.W. Stone et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J Am Coll Cardiol 43 2004 1773 1779
5. N. Ozasa, T. Kimura, T. Morimoto for the j-Cypher Registry Investigators Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention Am J Cardiol 106 2010 1225 1233
6. K.Y. Chen, S.W. Rha, Y.J. Li for the Korean Acute Myocardial Infarction Registry Investigators Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Circulation 119 2009 3207 3214
7. H.S. Jo, J.S. Park, and J.W. Sohn et al. Culprit-lesion-only versus multivessel revascularization using drug-eluting stents in patients with ST-segment elevation myocardial infarction: a Korean Acute Myocardial Infarction Registry-based analysis Korean Circ J 41 2011 718 725
8. S.H. Kang, J.W. Suh, and C.H. Yoon et al. Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry) Am J Cardiol 109 2012 787 793
9. E.M. Antman, D.T. Anbe, and P.W. Armstrong et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) J Am Coll Cardiol 44 2004 671 719
10. J.Y. Kim, M.H. Jeong, Y.K. Ahn for the Other Korea Acute Myocardial Infarction Registry Decreased glomerular filtration rate is an independent predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Korean Circ J 41 2011 184 190
11. K.H. Lee, M.H. Jeong, H.M. Kim for the KAMIR Investigators Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol J Am Coll Cardiol 58 2011 1664 1671
12. N. Hanna, M. Sun, and Q.D. Trinh et al. Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series Eur Urol 61 2012 715 721
13. D.B. Rubin The use of matched sampling and regression adjustment to remove bias in observational studies Biometrics 29 1973 185 203
14. D.B. Rubin, and N. Thomas Combining propensity score matching with additional adjustments for prognostic covariates J Am Stat Assoc 95 2000 573 585
15. R.W. Yeh, S. Sidney, M. Chandra, M. Sorel, J.V. Selby, and A.S. Go Population trends in the incidence and outcomes of acute myocardial infarction N Engl J Med 362 2010 2155 2165
16. Y. Seino Beta-blocker therapy for patients with acute myocardial infarction: implications in the post-successful PCI era in Japan Circ J 75 2011 1829 1830
17. J. López-Sendón, K. Swedberg, J. McMurray for the Task Force on Beta-Blockers of the European Society of Cardiology Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
18. J. Chen, M.J. Radford, Y. Wang, T.A. Marciniak, and H.M. Krumholz Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction? Arch Intern Med 160 2000 947 952
19. S. Bangalore, G. Steg, P. Deedwania for the REACH Registry Investigators Beta-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease JAMA 308 2012 1340 1349
20. D.L. Bhatt, P.G. Steg, E.M. Ohman for the REACH Registry Investigators International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis JAMA 295 2006 180 189
21. J. McMurray, L. Køber, and M. Robertson et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial J Am Coll Cardiol 45 2005 525 530
22. S.L. Kopecky Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction Am J Cardiol 98 2006 1115 1119